Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F9KX1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,920
Award facts
- Contract value 100% obligated
- $20,920.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency for Benlysta 200 mg/mL auto-injectors valued at $20,920.02. The contract, designated as a firm fixed-price delivery order with no set-aside, was executed on January 13, 2026, with an ultimate completion date of February 4, 2026. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child task order under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, which is valued at up to $999,999,999.00 and extends through December 2031.
Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor within the Defense Health Agency supply chain, delivering a comprehensive range of medications and medical supplies to support military healthcare operations globally. Benlysta (belimumab) is a monoclonal antibody treatment used for systemic lupus erythematosus, indicating that this order supports the therapeutic needs of military treatment facilities and veteran healthcare programs. The competitively awarded contract reflects the contractor's established capability to meet federal procurement requirements for specialized pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9KX1?
SPE2DR26F9KX1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9KX1 worth?
The government has obligated $20,920 on SPE2DR26F9KX1.
Is contract SPE2DR26F9KX1 an order under another contract?
Yes. SPE2DR26F9KX1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KX1 competed?
The extent of competition for SPE2DR26F9KX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award